Home Searching for the most effective screening system to identify cell-active inhibitors of β-secretase
Article
Licensed
Unlicensed Requires Authentication

Searching for the most effective screening system to identify cell-active inhibitors of β-secretase

  • O. Middendorp , U. Lüthi , F. Hausch and A. Barberis
Published/Copyright: June 1, 2005
Biological Chemistry
From the journal Volume 385 Issue 6

Abstract

The β-secretase BACE1 is an attractive drug target for reducing the level of the Alzheimers disease-promoting Aβ peptide in the brain. Whereas potent peptidomimetic in vitro inhibitors of BACE1 have been designed, screening approaches to identify cell-permeable small molecule inhibitors have had limited success so far. In the present minireview we summarize existing screening methods, discuss their scope of application in the drug discovery process and compare them to a novel cell-based screening system to identify BACE1 inhibitors by a positive yeast growth selection.

:
Published Online: 2005-06-01
Published in Print: 2004-06-07

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Highlight: 3rd General IPS Meeting/International Conference on Protease inhibitors
  2. Colon cancer: genomics and apoptotic events
  3. Interaction of calpastatin with calpain: a review
  4. Cathepsin L and Arg/Lys aminopeptidase: a distinct prohormone processing pathway for the biosynthesis of peptide neurotransmitters and hormones
  5. Searching for the most effective screening system to identify cell-active inhibitors of β-secretase
  6. Accumulation of mini-plasmin in the cerebral capillaries causes vascular invasion of the murine brain by a pneumotropic influenza A virus: implications for influenza-associated encephalopathy
  7. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors
  8. Human cathepsin F: expression in baculovirus system, characterization and inhibition by protein inhibitors
  9. Proteinases participating in the processing and activation of prolegumain in primary cultured rat macrophages
  10. Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation
  11. Growth phase-dependent production of a cell wall-associated elastinolytic cysteine proteinase by Staphylococcus epidermidis
  12. Evidence for an interaction between leptin, T cell costimulatory antigens CD28, CTLA-4 and CD26 (dipeptidyl peptidase IV) in BCG-induced immune responses of leptin- and leptin receptor-deficient mice
  13. Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family
  14. Identification of cysteine protease inhibitors that belong to cystatin family 1 in the cellular slime mold Dictyostelium discoideum
  15. High molecular weight kininogen as substrate for cathepsin B
  16. 'Dipeptidyl peptidase-IV activity and/or structure homologs' (DASH) in growth-modulated glioma cell lines
  17. The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A
  18. Metalloproteases with EGF, CUB, and thrombospondin-1 domains function in molting of Caenorhabditis elegans
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2004.056/html
Scroll to top button